Pathways

Clustering of Social and Physical Pain Variables and Their Association With Mortality in Two Population-Based Cohorts

Author(s): Kroenke, Candyce H; Alexeeff, Stacey; Kushi, Lawrence H; Kwan, Marilyn L; Matthews, Karen A

Psychosom Med. 2021 04 01;83(3):228-238.

PubMed abstract

Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors

Author(s): Cespedes Feliciano EM; Kwan ML; Kushi LH; Weltzien EK; Castillo AL; Caan BJ

Breast Cancer Res Treat. 2017 04;162(3):549-557. Epub 2017-02-07.

PubMed abstract

Impact of social and built environment factors on body size among breast cancer survivors: the Pathways Study

Author(s): Shariff-Marco S; Roh JM; Ambrosone C; Gomez SL; Gomez SL; et al.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):505-515. Epub 2017-02-02.

PubMed abstract

Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis

Author(s): Yao S; Zhang Y; Tang L; Roh JM; Laurent CA; Hong CC; Hahn T; Lo JC; Ambrosone CB; Kushi LH; Kwan ML

Breast Cancer Res Treat. 2017 02;161(3):501-513. Epub 2016-12-03.

PubMed abstract

BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study

Author(s): Greenlee H; Hershman DL; Shi Z; Kwan ML; Ergas IJ; Roh JM; Kushi LH

J Natl Cancer Inst. 2017 Feb 01;109(2):1-8.

PubMed abstract

Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early Stage Breast Cancer: The LACE and Pathways Studies

Author(s): Jones LW; Weltzien E; Sweeney C; Kroenke CH; Langholz BM; Dang C; Caan BJ; Caan BJ; et al.

Cancer Res. 2016 Sep 15;76(18):5415-22. Epub 2016-08-03.

PubMed abstract

A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL)

Author(s): Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Buono DL; Nathanson SD; Bovbjerg DH; Mandelblatt JS; Tsai WY; Jacobson JS; Hershman DL

Breast Cancer Res Treat. 2016 07;158(1):127-38. Epub 2016-06-10.

PubMed abstract

RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741

Author(s): Kwan ML; Quesenberry CP; Caan BJ

J Natl Cancer Inst. 2016 Jan;108(1).

PubMed abstract

Representativeness of breast cancer cases in an integrated health care delivery system

Author(s): Gomez SL; Shariff-Marco S; Von Behren J; Kwan ML; Kroenke CH; Keegan TH; Reynolds P; Kushi LH

BMC Cancer. 2015;15:688. Epub 2015-10-14.

PubMed abstract

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer

Author(s): Kwan ML; Quesenberry CP; Caan BJ

J Natl Cancer Inst. 2015 Jan;108(1). Epub 2015-11-11.

PubMed abstract

Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data

Author(s): Mandelblatt JS; Kushi L; et al.

J Oncol Pract. 2015 Jan;11(1):e1-8. Epub 2014-08-26.

PubMed abstract

Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer

Author(s): Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Hershman DL

Breast Cancer. 2014 Nov;21(6):780-5. Epub 2014-06-06.

PubMed abstract

Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: Prognostication of short and long term outcomes

Author(s): Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP; Castillo A; Factor RE; Kushi LH; Bernard PS

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):725-34. Epub 2014-02-12.

PubMed abstract

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: Differences by age, race, and tumor characteristics

Author(s): Sweeney C; Habel LA; Quesenberry CP; Shakespear K; Caan BJ; Caan BJ; et al.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):714-24. Epub 2014-02-12.

PubMed abstract

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression

Author(s): Kroenke CH; Sweeney C; Kwan ML; Quesenberry CP; Weltzien EK; Habel LA; Castillo A; Bernard PS; Factor RE; Kushi LH; Caan BJ

Breast Cancer Res Treat. 2014 Apr;144(3):689-99. Epub 2014-03-07.

PubMed abstract

Bone health history in breast cancer patients on aromatase inhibitors

Author(s): Kwan ML; Tang L; Ambrosone CB; Yao S; Yao S; et al.

PLoS ONE. 2014;9(10):e111477. Epub 2014-10-29.

PubMed abstract

A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions

Author(s): Hillyer GC; Hershman DL; Kushi LH; Lamerato L; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Rana S; Neugut AI

Breast. 2013 Aug;22(4):548-54. Epub 2012-10-27.

PubMed abstract

Racial Disparities in Posttraumatic Stress After Diagnosis of Localized Breast Cancer; The BQUAL Study

Author(s): Vin-Raviv N; Hillyer GC; Hershman DL; Galea S; Leoce N; Bovbjerg DH; Kushi LH; Kroenke C; Lamerato L; Ambrosone CB; Valdimorsdottir H; Jandorf L; Mandelblatt JS; Tsai WY; Neugut AI

J Natl Cancer Inst. 2013 Apr 17;105(8):563-72. Epub 2013 Feb 21.

PubMed abstract

Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study

Author(s): Shelton RC; Clarke Hillyer G; Hershman DL; Leoce N; Bovbjerg DH; Mandelblatt JS; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Neugut AI

Breast Cancer Res Treat. 2013 Feb;137(3):817-28. Epub 2012 Dec 22.

PubMed abstract

Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007

Author(s): Kurian AW; Lichtensztajn DY; Keegan TH; Leung RW; Shema SJ; Hershman DL; Kushi LH; Habel LA; Kolevska T; Caan BJ; Gomez SL

Breast Cancer Res Treat. 2013 Jan;137(1):247-60. Epub 2012 Nov 9.

PubMed abstract

Noninitiation of Adjuvant Chemotherapy in Women With Localized Breast Cancer: The Breast Cancer Quality of Care Study

Author(s): Neugut AI; Lamerato L; Hershman DL; et al.

J Clin Oncol. 2012 Nov 1;30(31):3800-9. Epub 2012 Sep 24.

PubMed abstract

Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL)

Author(s): Neugut AI; Lamerato L; Hershman DL; et al.

Breast Cancer Res Treat. 2012 Jul;134(1):419-28. Epub 2012 Apr 22.

PubMed abstract

The Breast Cancer Quality of Care Study (BQUAL): A Multi-Center Study to Determine Causes for Noncompliance with Breast Cancer Adjuvant Therapy

Author(s): Neugut AI; Lamerato L; Hershman DL; et al.

Breast J. 2012 May-Jun;18(3):203-13. Epub 2012 Apr 5.

PubMed abstract

Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer

Author(s): Livaudais JC; Hershman DL; Habel L; Kushi L; Gomez SL; Li CI; Neugut AI; Fehrenbacher L; Thompson B; Coronado GD

Breast Cancer Res Treat. 2012 Jan;131(2):607-17. Epub 2011 Sep 16.

PubMed abstract

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

Author(s): Hershman DL; Shao T; Kushi LH; Buono D; Tsai WY; Fehrenbacher L; Kwan M; Gomez SL; Neugut AI

Breast Cancer Res Treat. 2011 Apr;126(2):529-37. Epub 2010 Aug 28.

PubMed abstract

A practical method for collecting food record data in a prospective cohort study of breast cancer survivors

Author(s): Kwan ML; Kushi LH; Song J; Timperi AW; Boynton AM; Johnson KM; Standley J; Kristal AR

Am J Epidemiol. 2010 Dec 1;172(11):1315-23. Epub 2010 Oct 11.

PubMed abstract

Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study

Author(s): Kwan ML; Darbinian J; Schmitz KH; Citron R; Partee P; Kutner SE; Kushi LH

Arch Surg. 2010 Nov;145(11):1055-63.

PubMed abstract

Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake

Author(s): Christensen BC; Kwan ML; Wiencke JK; Wiencke JK; et al.

PLoS Genet. 2010 Jul 29;6(7):e1001043.

PubMed abstract

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

Author(s): Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L

J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. Epub 2008 Apr 8.

PubMed abstract